Hopp til innhold
NHI.no
Annonse

Svetteplager fra armhulene: Prognose

Prognosen er god ved behandling, men for noen er tilstanden en livslang plage.

Dette dokumentet er basert på det profesjonelle dokumentet Aksillær hyperhidrose . Referanselisten for dette dokumentet vises nedenfor

  1. Fischer-Rasmussen T, Printzlau A, Klyver H. Aksillær hyperhidrose. Ugeskr Læger 2004; 166: 3689-95. PubMed
  2. Altman RS, Schwartz RA. Emotionally induced hyperhidrosis. Cutis 2002; 69: 336-8. PubMed
  3. Atkins JL, Butler PE. Hyperhidrosis: a review of current management. Plast Reconstr Surg 2002; 110: 222-8. PubMed
  4. Togel B, Greve B, Raulin C. Current therapeutic strategies for hyperhidrosis: a review. Eur J Dermatol 2002; 12: 219-23. PubMed
  5. Hessam S, Sand M, Gambichler T, Bechara FG. Correlation of inflammatory serum markers with disease severity in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol. 2015 Sep 22. doi:10.1016/j.jaad.2015.08.052. DOI
  6. Fan YM, Wu ZH, Li SF et al. Axillary osmidrosis treated by partial removal of the skin and subcutaneous tissue en bloc and apocrine gland subcision. Int J Dermatol 2001; 40: 714-6. PubMed
  7. Park YJ, Shin MS. What is the best method for treating osmidrosis? Ann Plast Surg 2001; 47: 303-9. PubMed
  8. Rompel R, Scholz S. Subcutaneous curettage vs. injection of botulinum toxin A for treatment of axillary hyperhidrosis. J Eur Acad Dermatol Venereol 2001; 15: 207-11. PubMed
  9. Streker M, Reuther T, Verst S, Kerscher M. Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis. Hautarzt. 2010 Feb. 61(2):139-44.
  10. Kouris A, et al. Quality of life and social isolation in Greek adolescents with primary focal hyperhidrosis treated with Botulinum Toxin Type A: A case series. Pediatr Dermatol 2014. doi:10.1111/pde.12480 DOI
  11. Heckmann M, Ceballos-Baumann AO, Plewig G. Botulinum toxin A for axillary hyperhidrosis (excessive sweating). N Engl J Med 2001; 344: 488-93. New England Journal of Medicine
  12. Naumann M, Lowe NJ. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial. BMJ 2001; 323: 596-9. British Medical Journal
  13. Wollina U, Karamfilov T, Konrad H. High-dose botulinum toxin type A therapy for axillary hyperhidrosis markedly prolongs the relapse-free interval. J Am Acad Dermatol 2002; 46: 536-40. PubMed
  14. Lowe NJ, Glaser DA, Eadie N, et al, for the North American Botox in Primary Axillary Hyperhidrosis Clinical Study Group. Botulinum toxin type A in the treatment of primary axillary hyperhidrosis: A 52-week multicenter double-blind, randomized, placebo-controlled study of efficacy and safety. J Am Acad Dermatol 2007; 56: 604-11. PubMed
  15. Hong HC, Lupin M, O'Shaughnessy KF. Clinical evaluation of a microwave device for treating axillary hyperhidrosis. Dermatol Surg 2012; 38:728. PubMed
  16. Lupin M, Hong HC, OʼShaughnessy KF. Long-term efficacy and quality of life assessment for treatment of axillary hyperhidrosis with a microwave device. Dermatol Surg 2014; 40:805. PubMed
  17. Glaser DA, Galperin TA. Local procedural approaches for axillary hyperhidrosis. Dermatol Clin 2014; 32:533. PubMed
  18. Eisenach JH, Atkinson JL, Fealey RD. Hyperhidrosis: evolving therapies for a well-established phenomenon. Mayo Clin Proc 2005; 80: 657-66. PubMed
  19. Smith CC, Pariser D. Primary focal hyperhidrosis. UpToDate, last updated Oct 11, 2018. UpToDate
  20. Wolosker N, de Campos JR, Kauffman P, et al. A randomized placebo-controlled trial of oxybutynin for the initial treatment of palmar and axillary hyperhidrosis. J Vasc Surg 2012; 55: 1696-700 . PubMed
  21. Sbidian E, Hotz C, Seneschal J, et al. Anti-TNFα therapy for hidradenitis suppurativa. Results from a national cohort study between 2000 and 2013. Br J Dermatol, 2015 Sep 25. doi:10.1111/bjd.14199 DOI
  22. Neumayer CH, Bischof G, Fugger R et al. Efficacy and safety of thoracoscopic sympathicotomy for hyperhidrosis of the upper limb. Results of 734 sympathicotomies. Ann Chir Gynaecol 2001; 90: 195-9. PubMed
  23. Fischel R, Cooper M, Kramer D. Microinvasive resectional sympathectomy using the harmonic scalpel. A more effective procedure with fewer side effects for treating essential hyperhidrosis of the hands, face or axillae. Clin Auton Res 2003; 13 (Suppl 1): I66-70.
  24. Lardinois D, Ris HB. Minimally invasive video-endoscopic sympathectomy by use of a transaxillary single port approach. Eur J Cardiothorac Surg 2002; 21: 67-70. PubMed
  25. Panhofer P, Zacherl J, Jakesz R, Bischof G, Neumayer C. Improved quality of life after sympathetic block for upper limb hyperhidrosis. Br J Surg 2006; 93: 582-6. PubMed
Annonse
Annonse